Many of the communication and relationship-building skills that made Jan Hearn a great sales rep for nine years now make her a great corporate account manager. Promoted three years ago by Thousand Oaks, CA-based Amgen Inc., Hearn now works with corporate pharmacy staff, medical directors, CEOs, CFOs and COOs at five major integrated healthcare systems in three states to gain access and coverage for Amgen products. Although this new role required Hearn to undergo extensive training and master new skills, many challenges of relationship-building in the corporate environment aren't so different from those she faced as a rep.
Many of the communication and relationship-building skills that made Jan Hearn a great sales rep for nine years now make her a great corporate account manager. Promoted three years ago by Thousand Oaks, CA-based Amgen Inc., Hearn now works with corporate pharmacy staff, medical directors, CEOs, CFOs and COOs at five major integrated healthcare systems in three states to gain access and coverage for Amgen products. Although this new role required Hearn to undergo extensive training and master new skills, many challenges of relationship-building in the corporate environment aren't so different from those she faced as a rep.
Achieving productive dialogue can still be difficult. "You don't just walk into a CEO's office, sit down and talk. Just like a pharmaceutical rep, I need to build credibility, and I need to be sensitive to their time and needs." And like reps, Hearn must gain an in-depth knowledge of her customers and their business before she can meet those needs. "What are their goals? What are their mission statements as an organization?"
Although her customers are different, Hearn's goals in relationship-building now are the same as they were three years ago: "Just like in a pharmaceutical rep position, you reach that time in a relationship when you've earned credibility and respect from the customer, and you're able to advance to a long-term partnership. When you're able to spend time with a CEO talking about the value your company provides to patients, hospital and corporate staff, and the healthcare system, that is truly a win."
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.